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Appendix text: Analysis of GFP::IFT22 in T. brucei 
GFP::IFT22 was previously shown to traffic in the trypanosome flagellum (Adhiambo 
et al, 2009), but conditions for proper quantification were not available at the time. 
We therefore acquired videos of GFP::IFT22 trafficking and quantified the movement 
by kymograph analysis (Buisson et al, 2013). Anterograde movement of GFP::IFT22 
occurred at a frequency of 0.84 s
-1
 and at an average speed of 2.73 ± 0.69 µm/s (n = 
218). These values are in the same range as observed for GFP::IFT27 (Huet et al, 
2014) or GFP::IFT52 (Buisson et al, 2013). RNAi silencing of IFT22 surprisingly 
resulted in a defect of retrograde transport (Adhiambo et al, 2009). To confirm this 
phenotype was specific and not due to an off-target effect, an RNAi-resistant version 
of IFT22 was fused to GFP (GFP::IFT22rescue) to discriminate it from the product of 
the endogenous gene and expressed in the IFT22
RNAi
 cell line (Fig. S6A). For the sake 
of simplicity, this IFT22
RNAi
+GFP::IFT22 RNAi resistant cell line will be called 
IFT22R. Western blot analysis using an antiserum against IFT22 demonstrated that 
the GFP::IFT22rescue fusion protein displayed the expected motility on gel (expected 
MW of 52 kDa) and was detected alongside the endogenous protein (expected MW of 
24 kDa) (Fig. S6B). Video-microscopy on live cells demonstrated typical IFT 
trafficking (Appendix video S1). Addition of tetracycline triggered RNAi knockdown 
of the endogenous IFT22 with the same efficiency as in the IFT22
RNAi
 cell line alone 
(Fig. S6B) and, as expected, the GFP::IFT22rescue fusion protein was not affected (Fig. 
S6B, last lane). This result was confirmed in live cells (Appendix video S2). Of note, 
the signal-to-noise ratio for GFP-IFT22rescue in the flagellum was better in induced 
conditions, indicating a competition with the endogenous untagged IFT22 protein. 
Immunofluorescence assays (IFA) with an anti-IFT172 monoclonal antibody and a 
marker of the axoneme were used to further characterize the phenotypes (Fig. 6B). As 
expected, knockdown of IFT22 in the IFT22
RNAi
 cell line led to the emergence of cells 
with tiny flagella usually filled with IFT material (Fig. 6B, second row), as previously 
reported (Adhiambo et al, 2009). By contrast, expression of the GFP::IFT22rescue 
rescued the phenotype as these cells displayed normal IFT distribution and possess 
flagella of normal length (Fig. 6B, third row). These results formally prove that the 
phenotype is indeed due to IFT22 knockdown and not to off-target effects and 








Appendix Figure S1: IFT22 nucleotide analysis 
A. SDS-PAGE gels of purified IFT22 from T. brucei and M. musculus. (FL = full-
length) 
B. SEC profiles of TbIFT22 and MmIFT22. The SEC elution profiles for both native 
and refolded TbIFT22 are shown in different shades of green. 
C. HPLC nucleotide-elution profiles. Left: Nucleotide controls confirming that 
different G-nucleotides can be resolved. Right: Comparison of different 
procedures for nucleotide removal to obtain nucleotide-free IFT22. Treatment 
with 8 M urea effectively removed GTP carried along through co-purification 
from E. coli extracts. 
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D. SDS-PAGE gels of purified IFT22/74/81 core complexes from different 
organisms. IFT74/81 constructs were designed based on sequence alignments (see 
Fig. S3D) and resulting complexes are TbIFT22/74342-401/81397-450, CrIFT22/74398-
459/81390-442, MmIFT22/74352-406/81389-441. 
E. HPLC GTP-elution profiles of the indicated purified IFT22 proteins and 
IFT22/74/81 core complexes from different organisms. Same amounts of each 
protein (complex) were injected (20 µl, 100 µM). 
F. GTPase activity assay for TbIFT22 and the TbIFT22/74/81 core complex. The 
release of inorganic Phosphate (Pi) upon addition of 1 mM GTP to the proteins 
was followed for 20 min. As a negative control, hydrolysis of 1 mM GTP in 
buffer was monitored and subtracted from the protein curves for rate 









) were calculated based on a linear standard 
curve generated from different Pi concentrations (right image).  
G. Unbiased Fo-Fc electron density maps (green, 2.5 σ) of IFT22-bound nucleotides 
for structures solved in this study. IFT22 is shown in grey in cartoon 
representation in similar orientations for each structure and nucleotides are 
depicted as sticks. 
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Appendix Figure S2: Multiple sequence alignment of IFT22 homologs 
Clustal Omega multiple sequence alignment of homologous IFT22 sequences from 
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different organisms and the classical Rab GTPases Rab8A and Rab11A from 
H. sapiens. Surface conservation is shown according to ConSurf grades (only for 
IFT22 sequences). Secondary structure elements from the GTP-TbIFT22 crystal 
structure (green and yellow) are indicated above the sequence, as are residues 
interacting with IFT74 (orange dots) and IFT81 (grey dots). Conserved sequence 
motifs of small GTPases are marked with blue boxes with consensus sequences 
inscribed below. Residues mutated in this study are encircled. (Hs = Homo sapiens, 
Mm = Mus musculus, Dr = Danio rerio, Tb = Trypanosoma brucei, Cr = 





Appendix Figure S3: Probing the IFT22-74/81 interface 
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A. SDS-PAGE gels of purified bIFT22/7479-401/81x-450 complexes with (left, x = 1) 
and without (right, x = 143) IFT81 CH domain. Only the complex with CH 
domain crystallized. 
B. SEC profiles for the TbIFT22/7479-401/811-450 and TbIFT22/7479-401/81143-450 
complex. 
C. TbIFT22/7479-401/811-450 crystals. Crystallization solution: 15% (v/v) glycerol, 
7.5% (w/v) PEG4000 and 100 mM HEPES pH 7.5. 
D. Clustal Omega multiple sequence alignment of the IFT22-binding region of 
homologous IFT74 and IFT81 sequences from different organisms. Surface 
conservation is shown according to ConSurf grades. Secondary structure elements 
from the IFT22/74/81 crystal structure are indicated above the sequence, as well 
as residues interacting with IFT22 (green dots). Tetrahymena and Giardia are 
organisms lacking an IFT22 homolog. (Hs = Homo sapiens, Mm = Mus 
musculus, Dr = Danio rerio, Tb = Trypanosoma brucei, Cr = Chlamydomonas 
reinhardtii and Ce = Caenorhabditis elegans, Tt = Tetrahymena thermophila, Gi 
= Giardia intestinalis). 
E. Co-expression and Ni-NTA pulldown of WT and various TbIFT22 mutants with 
TbIFT74342-401/81397-450 core complexes. Figure panels labeled ‘Expression’ 
shows the total expression demonstrating that all IFT22 mutants are strongly 
expressed. The panels labeled ‘Ni pulldown’ demonstrate that some of the IFT22 
point mutants are no longer able to interact with IFT74/81 core complexes. 
F. (left) SEC profiles of TbIFT22, TbIFT22/7479-401/811-450 and TbIFT22 incubated 
with TbIFT22/7479-401/811-450 prior to SEC. (right) SDS-PAGE of the fractions 
from the SEC elution of ‘TbIFT22/7479-401/811-450 + TbIFT22’ shows that IFT22 
does not associate with the core complex, which is in contrast to co-expressed 
TbIFT22/7479-401/811-450. The zoom-in box shows that IFT811-450 has been partly 
degraded giving rise to at least 3 additional bands on the SDS-PAGE 
corresponding to 1-3kDa smaller size of IFT81 (confirmed by MS). 
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Appendix Figure S4: Interactions between coiled-coil regions of the IFT74/81 
complex. 
 Cartoon representation of the TbIFT74/81 coiled-coil scaffold (center). Dashed 
boxes indicate four distinct regions of interaction between the different coiled-
coils: ccI-ccII, ccII-ccIII, ccIII-ccIV and ccII-ccIII-ccV. Zoomed-in views show 





Appendix Figure S5: Structural comparison of different microtubule-binding 
CH domains. 
A. Cartoon representation of the crystal structure of the TbIFT81 CH domain with the 
unusual C-terminal helices αI and αII labeled. 
B. Cartoon representation of the crystal structure of the CrIFT81 CH domain (PDB 
ID: 4lvp) with a similar C-terminal helix orientation. 
C-D. Cartoon representation of the crystal structures of the microtubule-binding CH 
domains of HsNDC80 (PDB ID: 3iz0) and HsEB1 (PDB ID: 3co1). All structures 
are shown in the same orientation after superpositioning onto the TbIFT81 CH 
domain. The rmsd for each superposition is indicated. 
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E. Left: Cartoon representation of the relative position of αII helix and ccI that tethers 
the IFT81 CH domain onto coiled coil region ccI. Right: Zoomed-in view of 
interacting residues of αII and ccI. 
F. Cartoon representation of IFT74/81 and NDC80/NUF2 after superimposing the N-
terminal CH domains (dashed box). While the IFT81 CH domain interacts with 
the coiled-coil moiety of the IFT74/81 heterodimer, the NDC80 CH domain is 
fixed through interactions with the NUF2 CH domain resulting in different 





Appendix Figure S6: In vivo analysis of the IFT22D175A in Trypanosoma brucei 
A. Strategy used to evaluate the biological significance of IFT22 mutations. Boxes 
represent coding sequences and undulated lines correspond to mRNA. Cell lines 
used contain the two endogenous copies (trypanosomes are diploid) of IFT22, a 
single copy of an RNAi-resistant version (dashed blue) fused to GFP (green) 
expressed from the PFR (paraflagellar rod, a well-characterised flagellar gene, 
Bastin et al 1998) locus and a construct for expression of double-stranded IFT22 
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RNA under the control of tetracycline-inducible promoters. In the absence of 
tetracycline, there is no dsRNA and mRNAs originating from all three genes are 
present. However, addition of tetracycline triggers the production of dsRNA that 
result in degradation of transcripts from the endogenous genes but not from the 
recoded one.  
B. Western blot analysis of the indicated cell lines probed with the anti-IFT22 
antibody (bottom) and with an anti-PFR as loading control (top). 
C. Western blot analysis of the IFT22
RNAi
+GFP::IFT22D175A cell line probed with the 
anti-IFT22 antibody (bottom) and with an anti-BiP as loading control (top). These 
samples were loaded on a blot together with the samples shown in Fig. 6A and 
thus share the same lane for molecular markers. 
D. Kymographs showing the movement of the GFP::IFT22D175A in the presence (left) 
or the absence (right) of endogenous IFT22. Note the improved signal-to-noise 
ratio in the latter case. 
E. IFA in the indicated conditions using the mAb25 (marker for the axoneme, middle 
panels) and an anti-IFT172 antibody (marker for IFT, bottom panels). The top 
panels show the phase contrast image merged with DAPI (cyan) that stains 
nuclear and mitochondrial DNA. Scale bar is 5 µm. 










Appendix Figure S7: Ciliopathy-causing mutation of a conserved IFT81 leucine 
is located in the IFT22 binding site. 
A. Mapping of HsIFT81 L435 onto the TbIFT22/74/81 structure reveals that the 
corresponding L443 in TbIFT81 is located right in the interface with IFT22 
making several hydrophobic interactions (see displayed interactions in the box to 
the right). 
A. Sequence alignment of IFT81 residues from different organisms interacting with 
IFT22. The patient mutation L435 is encircled in blue and is a conserved leucine 
residue. 
C. Surface conservation display of the IFT74/81 region interacting with IFT22 
showing that L443 is part of a conserved IFT22-binding site. 
